Compare RITM & IRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RITM | IRTC |
|---|---|---|
| Founded | 2011 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.5B | 5.8B |
| IPO Year | N/A | 2016 |
| Metric | RITM | IRTC |
|---|---|---|
| Price | $11.78 | $160.09 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 13 |
| Target Price | $14.44 | ★ $217.31 |
| AVG Volume (30 Days) | ★ 8.3M | 601.0K |
| Earning Date | 02-03-2026 | 02-19-2026 |
| Dividend Yield | ★ 8.49% | N/A |
| EPS Growth | ★ 46.96 | N/A |
| EPS | ★ 1.45 | N/A |
| Revenue | ★ $3,961,432,000.00 | $702,573,000.00 |
| Revenue This Year | N/A | $27.42 |
| Revenue Next Year | $7.71 | $17.05 |
| P/E Ratio | $8.12 | ★ N/A |
| Revenue Growth | ★ 32.03 | 25.45 |
| 52 Week Low | $9.13 | $92.52 |
| 52 Week High | $12.74 | $212.00 |
| Indicator | RITM | IRTC |
|---|---|---|
| Relative Strength Index (RSI) | 61.01 | 39.48 |
| Support Level | $11.05 | $160.84 |
| Resistance Level | $12.04 | $174.36 |
| Average True Range (ATR) | 0.26 | 8.95 |
| MACD | 0.06 | -1.55 |
| Stochastic Oscillator | 75.47 | 25.32 |
Rithm Capital Corp operates as a real estate investment trust that provides capital and services to the real estate and financial services industries. The company aims to generate attractive risk-adjusted returns in all interest-rate environments through a complementary portfolio of investments and operating businesses. Its investment portfolio is composed of mortgage servicing-related assets (full and excess MSRs and servicer advances), residential securities (and associated call rights) loans (including single-family rental), and consumer loans. Its operating segments are Origination and Servicing; Investment Portfolio; Residential Transitional Lending; and Asset Management.
iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.